FASTKD2 and human memory: functional pathways and prospects for novel therapeutic target development for Alzheimer's disease and age-associated memory decline

Pharmacogenomics. 2015;16(5):429-32. doi: 10.2217/pgs.15.8.
No abstract available

Keywords: Alzheimer's disease; FASTKD2; apoptosis; cognitive aging; drug target; fas-associated serine/threonine kinase domains 2; functional genomics; inflammation; memory; microRNA; mitochondria.

Publication types

  • Editorial
  • Research Support, N.I.H., Extramural
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Aging / genetics
  • Aging / physiology
  • Alzheimer Disease / drug therapy*
  • Alzheimer Disease / genetics*
  • Apoptosis
  • Humans
  • Memory / physiology*
  • Memory Disorders / drug therapy*
  • Memory Disorders / genetics*
  • Protein Serine-Threonine Kinases / drug effects*
  • Protein Serine-Threonine Kinases / genetics*
  • Protein Serine-Threonine Kinases / physiology
  • Signal Transduction / drug effects*
  • Signal Transduction / genetics*

Substances

  • FASTKD2 protein, human
  • Protein Serine-Threonine Kinases